Research and development based on materials and systems technologies
First written in FY2016. 27 of 29 entries say "Restated". Latest entry: FY2026.
3 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The company has invested ¥142.6 billion over the past 5 years. To enhance the commercial potential of promising future themes and accelerate transformation, it plans to conduct approximately ¥200 billion in research and development over the 5-year period beginning in 2026.」
For research and development, the company cited cumulative investment of ¥142.6 billion over the past 5 years and plans to invest approximately ¥200 billion over the 5-year period beginning in 2026. - FY2025RestatedAnnual report
「The Group regards research and development as one of its key management priorities and is actively allocating resources to R&D, aiming to provide high-value-added, high-performance new products based on materials technology centered on fine ceramics and process technology.」
The company continues its basic policy of allocating resources to research and development based on materials and process technologies. - FY2024-Q3RestatedAnnual report
「Group-wide R&D expenses for the cumulative third quarter were ¥22.360 billion, including ¥1.296 billion in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The company continues to explain that there have been no material changes in its research and development activities and disclosed R&D expenses of ¥22.360 billion and external contract research expenses of ¥1.296 billion. - FY2024-Q2RestatedAnnual report
「Group-wide R&D expenses for the cumulative second quarter were ¥14.505 billion, including ¥821 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The company continues to explain that there have been no material changes in its research and development activities and disclosed first-half R&D expenses of ¥14.505 billion. - FY2024-Q1RestatedAnnual report
「Group-wide R&D expenses for the cumulative first quarter were ¥6.599 billion, including ¥315 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company reaffirmed its policy that there had been no material changes in its research and development activities. First-quarter R&D expenses were ¥6.599 billion, including ¥315 million in external contract research expenses. - FY2023RestatedAnnual report
「The Group regards research and development as one of its key management priorities and is actively allocating resources to R&D, aiming to provide high-value-added, high-performance new products based on materials technology centered on fine ceramics and process technology.」
The company continues its policy of treating research and development as a key priority and allocating resources based on materials and process technologies. R&D expenses were ¥26.157 billion. - FY2023-Q3RestatedAnnual report
「Group-wide R&D expenses for the cumulative third quarter were ¥18.105 billion, including ¥625 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The company reaffirmed its policy that there had been no material changes in its research and development activities and disclosed R&D expenses of ¥18.105 billion. - FY2023-Q2RestatedAnnual report
「Group-wide R&D expenses for the cumulative second quarter were ¥11.944 billion, including ¥423 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The company continues to explain that there have been no material changes in its research and development activities and disclosed first-half R&D expenses of ¥11.944 billion. - FY2023-Q1RestatedAnnual report
「Group-wide R&D expenses for the cumulative first quarter were ¥5.448 billion, including ¥206 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company reaffirmed its policy of continuing to prioritize research and development, confirmed that there had been no material changes in its research and development activities, and disclosed quarterly R&D expenses of ¥5.448 billion. - FY2022-Q3RestatedAnnual report
「Group-wide R&D expenses for the cumulative third quarter were ¥16.478 billion, including ¥599 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The company reaffirmed its policy that there had been no material changes in its research and development activities and disclosed cumulative third-quarter R&D expenses of ¥16.478 billion. - FY2021RestatedAnnual report
「The Group regards research and development as one of its key management priorities and is actively allocating resources to R&D, aiming to provide high-value-added, high-performance new products based on materials technology centered on fine ceramics and systems technology.」
The company continues its policy of treating research and development as a key priority and allocating resources based on materials and systems technologies. R&D expenses for the period were ¥22.448 billion. - FY2021-Q3RestatedAnnual report
「Group-wide R&D expenses for the cumulative third quarter were ¥16.066 billion, including ¥622 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The company continues its policy that there have been no material changes in its research and development activities and disclosed cumulative third-quarter R&D expenses of ¥16.066 billion. - FY2021-Q2RestatedAnnual report
「Group-wide R&D expenses for the cumulative second quarter were ¥10.715 billion, including ¥364 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The company continues to explain that there have been no material changes in its research and development activities and disclosed first-half R&D expenses of ¥10.715 billion. - FY2021-Q1RestatedAnnual report
「Group-wide R&D expenses for the cumulative first quarter were ¥5.124 billion, including ¥186 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company continues to explain that there have been no material changes in its research and development activities and disclosed quarterly R&D expenses of ¥5.124 billion. - FY2020RestatedAnnual report
「The Group regards research and development as one of its key management priorities and is actively allocating resources to R&D, aiming to provide high-value-added, high-performance new products based on materials technology centered on fine ceramics and systems technology.」
The company continues its policy of allocating resources to research and development based on materials and systems technologies. R&D expenses were ¥22.928 billion. - FY2020-Q3RestatedAnnual report
「Group-wide R&D expenses for the cumulative third quarter were ¥15.953 billion, including ¥720 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The company continues to explain that there have been no material changes in its research and development activities and disclosed cumulative third-quarter R&D expenses of ¥15.953 billion. - FY2020-Q2RestatedAnnual report
「Group-wide R&D expenses for the cumulative second quarter were ¥10.638 billion, including ¥375 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The company reaffirmed its policy that there had been no material changes in its research and development activities and disclosed first-half R&D expenses of ¥10.638 billion. - FY2020-Q1RestatedAnnual report
「Group-wide R&D expenses for the cumulative first quarter were ¥4.930 billion, including ¥197 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company continues to explain that there have been no material changes in its research and development activities and disclosed quarterly R&D expenses of ¥4.930 billion. - FY2019RestatedAnnual report
「The Group regards research and development as one of its key management priorities and is actively allocating resources to R&D, aiming to provide high-value-added, high-performance new products based on materials technology centered on fine ceramics and systems technology.」
The company continues its policy of treating research and development as a key priority and allocating resources based on materials and systems technologies. R&D expenses were ¥23.271 billion. - FY2019-Q3RestatedAnnual report
「Group-wide R&D expenses for the cumulative third quarter were ¥16.905 billion, including ¥1.615 billion in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The company continues to explain that there have been no material changes in its research and development activities and disclosed cumulative third-quarter R&D expenses of ¥16.905 billion. - FY2019-Q2RestatedAnnual report
「Group-wide R&D expenses for the cumulative second quarter were ¥10.589 billion, including ¥481 million in expenses related to contract research conducted for parties outside the Group. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The company reaffirmed its policy that there had been no material changes in its research and development activities and disclosed first-half R&D expenses of ¥10.589 billion. - FY2018RestatedAnnual report
「The Group regards research and development as one of its key management priorities and is actively allocating resources to R&D, aiming to provide high-value-added, high-performance new products based on materials technology centered on fine ceramics and systems technology.」
The company continues its policy of treating research and development as a key priority and allocating resources based on materials and systems technologies. R&D expenses were ¥21.1 billion. - FY2018-Q3RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
The company continues to explain that there have been no material changes in its research and development activities. R&D expenses for the cumulative third quarter were ¥15.175 billion. - FY2018-Q2RestatedAnnual report
「There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company has reaffirmed its explanation that there have been no material changes in its research and development activities. R&D expenses for the cumulative second quarter were ¥9.977 billion. - FY2018-Q1RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The company has reaffirmed its explanation that there have been no material changes in its research and development activities. - FY2017RestatedAnnual report
「The Group regards research and development as one of its key management priorities and is actively allocating resources to R&D, aiming to provide high-value-added, high-performance new products based on materials technology centered on fine ceramics and systems technology.」
The company continues its policy of treating research and development as a key priority and allocating resources based on materials and systems technologies. R&D expenses were ¥18.653 billion. - FY2017-Q3RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
The company continues to explain that there have been no material changes in its research and development activities. - FY2017-Q2RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
The Group explicitly states that there were no material changes in its research and development activities. - FY2016First statedAnnual report
「The Group regards research and development as one of its key management priorities and is actively allocating resources to R&D, aiming to provide high-value-added, high-performance new products based on materials technology centered on fine ceramics and systems technology.」
The Group positions research and development as a key management priority and bases it on materials and systems technologies. Group-wide R&D expenses are stated as ¥17.410 billion.